Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000231116 | SCV000287109 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697256 | SCV000532896 | likely benign | not provided | 2019-04-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22368300, 32376792) |
ARUP Laboratories, |
RCV001697256 | SCV002506292 | likely benign | not provided | 2022-02-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002378983 | SCV002696455 | likely benign | Inborn genetic diseases | 2018-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001697256 | SCV004135210 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | DYNC1H1: BP4, BS1 |
Clinical Genetics, |
RCV001697256 | SCV001924669 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001697256 | SCV001926483 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001697256 | SCV001968434 | likely benign | not provided | no assertion criteria provided | clinical testing |